Skip to main content

Table 6 Comparison of cytokine levels between anti-MDA5-positive and anti-MDA5-negative patients in PM/DM

From: Clinical significance of interleukin-6, total bilirubin, CD3 + CD4 + T cells counts in the acute exacerbation of connective tissue disease-associated interstitial lung disease: a cross-sectional study

Variables

Anti-MDA5-positive PM/DM-ILD (n = 8), pg/mL

Anti-MDA5-negative PM/DM-ILD (n = 6), pg/mL

P value

IL-2

0.5 (0.2–1.3)

1.6 (1.1–2.4)

0.081

IL-4

1.1 (0.3–1.4)

3.2 (1.5–3.8)

0.020*

IL-5

0.4 (0.3–1.1)

1.1 (0.8–1.4)

0.181

IL-6

26.5 (8.8–58.1)

5.7 (5.2–12.3)

0.142

IL-8

197.2 (27.5–648.5)

41.8 (15.4–110.3)

0.181

IL-10

4.1 (3.2–6.8)

5.4 (4.5–8.1)

0.491

IL-1β

3.0 (2.2–6.7)

6.0 (4.1–7.9)

0.181

IL-17A

9.7 (6.6–13.1)

10.6 (6.1–22.8)

0.662

IL-12p70

2.3 (1.3–3.2)

5.0 (3.8–6.6)

0.020*

TNF-α

4.7 (1.5–18.2)

4.4 (3.0–5.8)

0.950

IFN-α

5.3 (1.5–10.4)

4.2 (2.0–8.5)

0.852

IFN-γ

3.1 (1.5–6.7)

5.4 (2.2–6.4)

0.414

  1. MDA5, melanoma differentiation-associated gene 5; PM/DM-ILD, polymyositis/dermatomyositis associated interstitial lung disease
  2. *P < 0.05